Cargando…
Use of Benzodiazepines in Alzheimer’s Disease: A Systematic Review of Literature
BACKGROUND: Benzodiazepines are frequently prescribed in patients with Alzheimer’s disease. Unfortunately, studies evaluating their benefits and risks in these patients are limited. METHODS: Clinical trials focusing on the effect of benzodiazepines on cognitive functions, disease progression, behavi...
Autores principales: | Defrancesco, Michaela, Marksteiner, Josef, Fleischhacker, W. Wolfgang, Blasko, Imrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648159/ https://www.ncbi.nlm.nih.gov/pubmed/25991652 http://dx.doi.org/10.1093/ijnp/pyv055 |
Ejemplares similares
-
Saliva tau and phospho-tau-181 measured by Lumipulse in patients with Alzheimer’s disease
por: Marksteiner, Josef, et al.
Publicado: (2022) -
Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer’s disease
por: Marksteiner, Josef, et al.
Publicado: (2017) -
Changes in White Matter Integrity before Conversion from Mild Cognitive Impairment to Alzheimer’s Disease
por: Defrancesco, Michaela, et al.
Publicado: (2014) -
Two Blood Monocytic Biomarkers (CCL15 and p21) Combined with the Mini-Mental State Examination Discriminate Alzheimer's Disease Patients from Healthy Subjects
por: Hochstrasser, Tanja, et al.
Publicado: (2011) -
Positionspapier der Österreichische Alzheimer Gesellschaft (ÖAG): Auswirkungen der COVID-19-Pandemie in Österreich auf Menschen mit Demenz und deren Betreuungsumfeld – Problemfelder, Empfehlungen und Strategien
por: Defrancesco, Michaela, et al.
Publicado: (2020)